Gastroparesis
📧 Sign up to get email alerts when something new happens for Gastroparesis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: Transcutaneous Electrical Acustimulation (TEA) for Gastroparesis [NA]
A clinical trial evaluating Transcutaneous Electrical Acustimulation for gastroparesis in patients with diabetes mellitus has completed.
-
CLINICAL_TRIALS research · 2025-08-24Clinical Trial Update: Single-Patient Expanded Access Protocol for Tradipitant In A Single Patient With Gastroparesis
This update describes a single-patient expanded-access protocol for Tradipitant in gastroparesis (including diabetic gastroparesis), sponsor…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Laparoscopic Implantation of a Gastric Pacemaker in the Treatment of Gastroparesis
A recruiting clinical trial is evaluating laparoscopic implantation of a gastric pacemaker to treat gastroparesis, including several subtype…
-
CLINICAL_TRIALS withdrawal · 2025-08-03Clinical Trial Update: Transauricular Vagal Nerve Stimulation; Functional Dyspepsia and Gastroparesis [NA]
A clinical trial evaluating transauricular vagal nerve stimulation for gastroparesis and functional dyspepsia has been withdrawn.
-
FDA approval · 2025-08-01FDA Approved: METOCLOPRAMIDE — Supplemental Application (Ipca Laboratories Limited)
The FDA approved a supplemental application for metoclopramide from Ipca Laboratories Limited, indicating an approved change to the ANDA.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: IVIG for Drug and Device Refractory Gastrointestinal Auto-Immune Neuropathy
This clinical trial update indicates that intravenous immunoglobulin (IVIG) is being studied for drug- and device-refractory gastrointestina…
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Impact of Per Oral Pyloromyotomy (POP) on Glycemic Control in Diabetes [NA]
A clinical trial update indicates a recruiting study assessing whether per oral pyloromyotomy improves glycemic control in diabetes, includi…
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: TENS in Scleroderma [Phase 1]
A Phase 1 clinical trial update on using a TENS device for patients with systemic sclerosis (scleroderma) and associated gastroparesis, curr…
-
CLINICAL_TRIALS withdrawal · 2025-06-29Clinical Trial Update: Treatment Use of Domperidone for Gastroparesis
This clinical trial update indicates that the domperidone trial for gastroparesis is no longer available.
-
CLINICAL_TRIALS withdrawal · 2025-06-25Clinical Trial Update: Comparison of Outcomes for Single vs Double Pyloromyotomy for Gastroparesis Randomized Controlled Trial [NA]
A randomized controlled trial comparing single versus double pyloromyotomy for gastroparesis has been withdrawn from the study registry. Spo…
-
CLINICAL_TRIALS trial_result · 2025-05-25Clinical Trial Update: Validation of Plant-Based Vegan Meal for Gastric Emptying Testing in 10 Healthy Subjects [NA]
This completed study evaluated whether a plant-based vegan meal can serve as a standardized test meal for gastric emptying in 10 healthy sub…
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Gastric Electrical Stimulation (GES) and Pyloroplasty for the Treatment of Gastroparesis [NA]
A completed clinical trial evaluated gastric electrical stimulation (GES) with pyloroplasty as treatments for gastroparesis. The study was s…
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Gastroparesis as an Early Sign of Sepsis
A completed clinical trial from Meir Medical Center studied gastroparesis as a potential early sign of sepsis (NCT06240585).
-
CLINICAL_TRIALS trial_result · 2025-04-30Clinical Trial Update: Pioglitazone for Idiopathic Gastroparesis [EARLY_Phase 1]
A Phase 1 trial of pioglitazone for idiopathic gastroparesis has completed and results have been posted.
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes [NA]
An ongoing ClinicalTrials.gov study is evaluating continuous glucose metrics in adults with diabetes and gastroparesis. The trial includes p…
-
CLINICAL_TRIALS research · 2025-03-27Clinical Trial Update: Predicting Outcomes of GPOEM Using Gastric Electrical Mapping
This clinical trial investigates whether gastric electrical mapping can predict outcomes after gastric peroral endoscopic myotomy (GPOEM) in…
-
CLINICAL_TRIALS research · 2025-03-26Clinical Trial Update: Body Surface Gastric Mapping in Patients on Semaglutide
A clinical trial is evaluating body surface gastric mapping in patients taking semaglutide to study gastric motility, with recruitment ongoi…
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: A Study to Evaluate Safety and Effectiveness of G-POEM for Gastroparesis [NA]
A Mayo Clinic-sponsored clinical trial evaluating the safety and effectiveness of G-POEM (gastric peroral pyloromyotomy) for gastroparesis h…
-
CLINICAL_TRIALS withdrawal · 2025-03-05Clinical Trial Update: The Use Of Domperidone For The Relief Of Refractory Upper Gastrointestinal GI Symptoms
A Yale-sponsored clinical trial evaluating domperidone for refractory upper GI symptoms in gastroparesis is no longer available.
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: Prokinetics and Body Surface Gastric Mapping in Dyspeptic Patients: Baseline and Treatment Effects
Clinical trial evaluating prokinetics and body surface gastric mapping in patients with gastroparesis and functional dyspepsia; currently no…
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: Body Surface Gastric Mapping Vs Gastric Emptying Scintigraphy on Clinical Management in Gastroparesis [NA]
A clinical trial is assessing whether body surface gastric mapping improves clinical management of gastroparesis compared with gastric empty…
-
CLINICAL_TRIALS research · 2025-02-20Clinical Trial Update: Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis [Phase 3]
Open-label safety study of Tradipitant in idiopathic and diabetic gastroparesis is currently recruiting in Phase 3.
-
CLINICAL_TRIALS research · 2025-02-17Clinical Trial Update: Transpyloric Stenting As a Predictor for G-POEM for Refractory Gastroparesis [NA]
This clinical trial update describes a study (NCT04287647) evaluating whether transpyloric stenting can predict the effectiveness of G-POEM …
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: ABVN Phase 2-Studying the Effect of Stimulation on the Auricular Branch of the Vagal Nerve -B [NA]
A clinical trial update indicates a Phase 2 study evaluating stimulation of the auricular branch of the vagal nerve for gastroparesis has co…
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: Effects of Liraglutide on Body Surface Gastric Mapping [NA]
Clinical trial completed evaluating the effects of liraglutide on body surface gastric mapping for gastroparesis and functional dyspepsia.